152 related articles for article (PubMed ID: 8303587)
1. [The detection of preventive hypofibronectinemia in diagnosing the development of disseminated intravascular coagulation in patients with myocardial infarction at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Soroka VR
Ter Arkh; 1993; 65(9):22-4. PubMed ID: 8303587
[TBL] [Abstract][Full Text] [Related]
2. [Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Ignashenkova GV; Dikov MM
Ter Arkh; 1987; 59(10):21-3. PubMed ID: 3324376
[TBL] [Abstract][Full Text] [Related]
3. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte equidistance and heavy metals in the pathogenesis of disseminated intravascular coagulation in myocardial infarct patients at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Soroka VR
Lik Sprava; 1993; (10-12):30-4. PubMed ID: 8030303
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the fragments of FDP in 4 patients with DIC].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Oct; 40(10):1089-95. PubMed ID: 1307614
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
7. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
8. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
9. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation.
Mosher DF; Williams EM
J Lab Clin Med; 1978 May; 91(5):729-35. PubMed ID: 641397
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
13. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
[TBL] [Abstract][Full Text] [Related]
14. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
15. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of fibrinogen degradation products.
Bick RL
Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
[No Abstract] [Full Text] [Related]
17. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
[TBL] [Abstract][Full Text] [Related]
18. [Absence of fibronectin in a 40-day-old child who died as a result of septicemia with disseminated intravascular coagulation].
Blanco A; Solís P; Guisasola JA; Arranz E; Tellería JJ; Blanco C
Sangre (Barc); 1989 Feb; 34(1):59-62. PubMed ID: 2711287
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of immature platelet fraction and plasma thrombopoietin in disseminated intravascular coagulation.
Hong KH; Kim HK; Kim JE; Jung JS; Han KS; Cho HI
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):409-14. PubMed ID: 19528793
[TBL] [Abstract][Full Text] [Related]
20. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
